2020
DOI: 10.1016/j.imlet.2020.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren’s syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…NOD/ShiLtJ mice are commonly used as a type 1 diabetes model, as, depending on the conditions, approximately 50–80% of female NOD/ShiLtJ mice spontaneously develop type 1 diabetes. Moreover, these mice also display a propensity for polyautoimmunity, including a low incidence of autoimmune thyroiditis and Sjögren’s syndrome [ 42 ]. This was also confirmed in our study, as vehicle exposed NOD/ShiLtJ mice displayed low ANA positivity, while C57BL/6J mice did not exhibit ANA positivity under vehicle exposure.…”
Section: Discussionmentioning
confidence: 99%
“…NOD/ShiLtJ mice are commonly used as a type 1 diabetes model, as, depending on the conditions, approximately 50–80% of female NOD/ShiLtJ mice spontaneously develop type 1 diabetes. Moreover, these mice also display a propensity for polyautoimmunity, including a low incidence of autoimmune thyroiditis and Sjögren’s syndrome [ 42 ]. This was also confirmed in our study, as vehicle exposed NOD/ShiLtJ mice displayed low ANA positivity, while C57BL/6J mice did not exhibit ANA positivity under vehicle exposure.…”
Section: Discussionmentioning
confidence: 99%
“…NOD/ShiLtJ mice are commonly used as a type 1 diabetes model, as, depending on the conditions, approximately 50–80% of female NOD/ShiLtJ mice spontaneously develop type 1 diabetes. Moreover, these mice also display a propensity for polyautoimmunity, including a low incidence of autoimmune thyroiditis and Sjögren’s syndrome ( 48 ). This was also confirmed in our study, as vehicle exposed NOD/ShiLtJ mice displayed low ANA positivity, while C57BL/6J mice did not exhibit ANA positivity under vehicle exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Compared with the control group, NOD mice treated with the CD40 DNA vaccine showed reduced lymphocyte infiltration and increased salivary secretion in salivary glands. At the same time, the expression levels of TNF-α and IL-6 in salivary glands decreased, the number of dendritic cells and plasma cells decreased, and the ANA level decreased ( 211 ). Iscalimab, an anti-CD40 antibody, has been shown to be safe and well tolerated at all doses in phase I clinical studies, with no clinically relevant changes in any of the safety parameters, including no evidence of thromboembolic events ( 212 ).…”
Section: Treatmentmentioning
confidence: 99%